论文部分内容阅读
传统的气道扩张药包括β2受体激动剂和M胆碱能受体抑制剂,前者主要促进支气管平滑肌松弛,后者引起支气管扩张。随着人们对哮喘的病因认识有了实质性的进展,认为哮喘性气道狭窄是气管的炎症所致,由此导致了气管的高反应性,于是一些抗炎药物如糖皮质激素、与白三烯介质有关的药物、其他过敏介质抑制剂等也用于抗哮喘疾病的治疗,这些药物称为抗炎性平喘药。现将平喘药在呼吸系统疾病中的应用总结如下,希望引起同道的重视。
Traditional airway dilatation drugs include β2 receptor agonists and M cholinergic receptor inhibitors, the former mainly to promote bronchial smooth muscle relaxation, the latter caused by bronchiectasis. With people’s understanding of the etiology of asthma has made substantial progress, that airway stenosis is the result of bronchial inflammation, which led to the high reactivity of the trachea, so some anti-inflammatory drugs such as glucocorticoids, and white Triene media-related drugs, other allergic media inhibitors, etc. are also used for the treatment of asthma, these drugs are called anti-inflammatory asthma drugs. The application of antiasthmatic drugs in respiratory diseases are summarized as follows, hoping to arouse the attention of the same people.